Last quarter (Q3 2023), BioCorRx's total revenue was $10.10K, a decrease of -89.31% from the same quarter last year. In Q3, BioCorRx's net income was $-866.30K. See BioCorRx’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 153.06K	$ 213.84K	$ 48.27K	$ 122.62K	$ 240.26K	$ 376.66K
Cost of Revenue	$ -7.14M	$ 18.95K	$ 5.88K	$ 95.95K	$ 81.67K	$ 170.95K
Gross Profit	$ 147.15K	$ 213.84K	$ 48.27K	$ 26.67K	$ 158.59K	$ 205.70K
Operating Expense	$ 1.77M	$ 4.91M	$ 5.42M	$ 3.05M	$ 4.63M	$ 4.58M
Operating Income	$ -3.10M	$ -4.70M	$ -5.37M	$ -3.03M	$ -4.47M	$ -4.38M
Net Non Operating Interest Income Expense	$ -1.50M	$ -1.09M	$ -565.68K	$ -510.96K	$ -1.62M	$ -1.96M
Other Income Expense	$ -3.29M	$ -1.74M	$ -797.41K	$ 31.80K	$ 44.31K	$ -249.15K
Pretax Income	$ 1.05K	$ -4.38M	$ -5.28M	$ -3.51M	$ -6.05M	$ -6.58M
Tax Provision	-	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 8.41K	$ -4.34M	$ -5.28M	$ -3.47M	$ -6.04M	$ -6.51M
Basic EPS	-	-	-	$ -0.65	$ -1.71	$ -2.60
Diluted EPS	-	-	$ -0.81	$ -0.65	$ -1.71	$ -2.60
Basic Average Shares	-	-	$ 6.49M	$ 5.38M	$ 3.52M	$ 2.51M
Diluted Average Shares	$ 3.25M	$ 1.45M	$ 1.06M	$ 5.38M	$ 3.52M	$ 2.51M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ -5.38M	$ 4.93M	$ 5.42M	$ 3.15M	$ 4.71M	$ 4.75M
Net Income From Continuing And Discontinued Operation	$ 6.43K	$ -4.38M	$ -5.28M	$ -3.47M	$ -6.04M	$ -6.51M
Normalized Income	$ -1.41M	$ 3.71M	-	$ -3.47M	$ -6.04M	$ -6.26M
Interest Expense	-	-	-	$ 510.96K	$ 1.62M	-
EBIT	$ 1.50M	$ -3.29M	$ -4.71M	$ -3.00M	$ -4.43M	$ -4.38M
EBITDA	$ 1.87M	$ -2.65M	$ -4.65M	$ -2.83M	$ -4.33M	$ -4.37M

Currency in USD

BioCorRx Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing